TWD 30.05
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -26.3 Million TWD | -138.33% |
2022 | -10.93 Million TWD | -612.86% |
2021 | -361 Thousand TWD | -103.69% |
2020 | 43.28 Million TWD | -3.02% |
2019 | 43.22 Million TWD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -15.39 Million TWD | 0.0% |
2024 Q1 | -15.39 Million TWD | -32.55% |
2023 Q3 | -11.61 Million TWD | -658.08% |
2023 Q1 | -1.53 Million TWD | 78.3% |
2023 Q2 | -1.53 Million TWD | 0.0% |
2023 Q4 | -11.61 Million TWD | 0.0% |
2022 FY | - TWD | -612.86% |
2022 Q4 | -7.06 Million TWD | 0.0% |
2021 FY | - TWD | -103.69% |
2020 FY | - TWD | -3.02% |
2019 FY | - TWD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Bio Preventive Medicine Corp. | -62.34 Million TWD | 57.813% |
Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 74.618% |
Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 67.155% |
Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 81.983% |
NaviFUS Corp. | -55.79 Million TWD | 52.863% |
G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 126.343% |
TaiRx, Inc. | -208.64 Million TWD | 87.395% |
Sinew Pharma Inc. | -163.63 Million TWD | 83.927% |
Lin BioScience, Inc. | -1.07 Billion TWD | 97.545% |
TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -1414.105% |
Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 88.398% |
Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 43.128% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 106.682% |
AP Biosciences Inc | -325.51 Million TWD | 91.92% |
Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 102.808% |
RBC Bioscience Corporation | 36.54 Million TWD | 171.962% |
Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 106.066% |
EirGenix Inc. | -664.4 Million TWD | 96.042% |
Enimmune corporation | -228.96 Million TWD | 88.513% |
BRIM Biotechnology, Inc. | -682.46 Million TWD | 96.146% |
3D Global Biotech Inc. | -35.84 Million TWD | 26.631% |
TaiMed Biologics Inc. | -25.23 Million TWD | -4.229% |
Mycenax Biotech Inc. | -339.48 Million TWD | 92.253% |
TCI GENE Inc. | 25.98 Million TWD | 201.228% |
SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -48.37% |
Oneness Biotech Co., Ltd. | -674.22 Million TWD | 96.099% |
Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 41.492% |
Feng Chi Biotech Corp. | 34.83 Million TWD | 175.492% |
NeoCore Technology Co., Ltd. | -72.11 Million TWD | 63.53% |
TWi Biotechnology, Inc. | -160.85 Million TWD | 83.65% |
Neith Corporation | -33.61 Million TWD | 21.749% |
Sunny Pharmtech Inc. | 69.14 Million TWD | 138.037% |
VBI | -6.97 Million TWD | -277.223% |
Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 104.012% |
GeneReach Biotechnology Corp. | -143.69 Million TWD | 81.697% |
Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 20.318% |
CHO Pharma, Inc. | -277.73 Million TWD | 90.53% |
Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 57.236% |
MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 76.229% |
Visgeneer Inc. | 973 Thousand TWD | 2802.98% |
Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 113.669% |
BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 135.587% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -58.453% |
Sagittarius Life Science Corp | -44.73 Million TWD | 41.215% |
BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 76.747% |
GlycoNex Incorporation | -126.82 Million TWD | 79.263% |
Medigen Biotechnology Corp. | -1.04 Billion TWD | 97.482% |
Pharmosa Biopharm Inc. | 29.13 Million TWD | 190.285% |
PharmaEngine, Inc. | 347.3 Million TWD | 107.573% |
Intech Biopharm Corporation | -219.58 Million TWD | 88.023% |
Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 220.587% |
BiOptic Inc. | 65.03 Million TWD | 140.438% |
TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 115.27% |
Senhwa Biosciences, Inc. | -283.78 Million TWD | 90.732% |
NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 289.892% |
OBI Pharma, Inc. | -855.08 Million TWD | 96.924% |
Savior Lifetec Corporation | 219.6 Million TWD | 111.976% |
Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 52.108% |
Level Biotechnology Inc. | 98.7 Million TWD | 126.645% |
Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 97.346% |
Meribank Biotech Co., Ltd | -92.56 Million TWD | 71.587% |
Acepodia, Inc. | -764.51 Million TWD | 96.56% |
Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 94.284% |